Company Overview and News

19
Berkshire Hathaway Significant Quarterly Changes

1h seekingalpha
The changes in holdings that occurred at Berkshire Hathaway (BRK.A) (BRK.B) in its investment portfolio were relatively minor over the latest quarter compared to previous quarters. Today, we will list the changes and rate those purchases and sales with our Friedrich algorithm.
PSX USB BRK.A CHTR BK OCLCF AAPL GM ORCL

14
Tesla: JPMorgan dramatically slashes stock price forecast

5h money.cnn
At least that's what JPMorgan Chase thinks. The Wall Street firm dramatically slashed its price target on Elon Musk's car company on Monday, causing Tesla shares to briefly tumble.
NYTAB GM

66
Tesla Should Go Private, But Don’t Bank on It Happening | InvestorPlace

5h investorplace - 1
There’s no denying that electric vehicle maker Tesla (NASDAQ:TSLA) has some pretty amazing technology and products. There’s also no denying that TSLA is a pretty poorly run company with terrible financials. Despite the lack of profits, high debts and other mishaps, shares of Tesla continue to have plenty of fans.
F TSLA GM

14
Nissan to boost China production capacity by 40%, source says

5h theedgemarkets
BEIJING (Aug 20): Japan's Nissan Motor Co plans to invest about US$900 million to boost vehicle-making capacity in China by 40% by 2021 — part of a 60 billion yuan (US$8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

14
Tesla nears three-month low as JPMorgan adds to deal doubts

6h channelnewsasia
Tesla Inc shares fell 7 percent early on Monday as a US$113 cut in JPMorgan Chase's price target for the electric carmaker added to growing doubts among market players about a plan to take the company private.
NYTAB GM

14
Nissan to boost China production capacity by 40 percent, source says

7h channelnewsasia
Japan's Nissan Motor Co plans to invest about US$900 million to boost vehicle-making capacity in China by 40 percent by 2021 - part of a 60 billion yuan (US$8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

14
UPDATE 1-Nissan to boost China production capacity by 40 pct, source says

7h reuters
BEIJING (Reuters) - Japan’s Nissan Motor Co (7201.T) plans to invest about $900 million to boost vehicle-making capacity in China by 40 percent by 2021 - part of a 60 billion yuan ($8.73 billion) strategy to become a top three player in the world’s largest auto market.
VLKAF TM 7203 TYT GM TOYOF

136
Revisiting the Trump Portfolios - The Big Picture

8h ritholtz
Betting Against Trump Was a Market-Beater The companies the president disparaged have done much better than those he favored. Bloomberg, January 10, 2018
STZ.B XOM TWX GLSSP TWTR JBK TMUSP TMUS TFG TYT STZ UTX TWC 7203 9984 BA LMT FB TM PYPL SFTBF GS BOE GM SFTBY CLNS GSC NYTAB TOYOF GSJ S RXN PEP CLNY TSLA GJS

24
Crispin Odey says Tesla feels like it’s entering final stage of life

13h livemint
Crispin Odey said Tesla Inc.’s short sellers may finally start to see their bets against the electric carmaker pay off. “Shorts like Tesla have been difficult to hold on to,” the hedge fund manager wrote in a letter to investors. “However, Tesla feels like it is entering the final stage of its life,” he wrote, comparing chairman Elon Musk’s behaviour to that of Donald Crowhurst, the amateur sailor who set off in the 1960s on a solo voyage around the world and never came back.
BABA NYTAB GM

14
New Hoong Fatt ramps up overseas expansion

19h theedgemarkets
KUALA LUMPUR: New Hoong Fatt Holdings Bhd (NHF), unfazed by local debate over a third national car, is not overly concerned about talks of policy changes in the local automotive market as it expands its opportunities in Asean.
TM 7060 7203 TYT GM TOYOF

66
Tesla Is Still Worth More Than GM

2018-08-19 247wallst - 3
Despite a sell-off in Tesla, Inc’s (NASDAQ: TSLA) stock due to the erratic behavior of CEO Elon Musk, SEC scrutiny of his public statements, rumored turmoil among board members, and risks that it can’t hit production targets, the electric car company’s market value is still higher than that of General Motors Company (NYSE: GM). GM sells about 10 million cars a year. Tesla delivered slightly more than 40,000 last quarter.
TSLA GM

36
Your 50 Top S&P 500 Stocks For Yield, Gains & Upside For August

2018-08-19 seekingalpha - 1
"The S&P 500 is widely-regarded as the best single gauge of large-cap U.S. equities. The index includes 500 leading companies and captures approximately 80% coverage of available market capitalization."---us.spindices.com.
VTR PM XOM NLSN LB KMI KHC WMB PPL WELL GM KMR CVB KMRFZ IVZ COTY

33
Apple Returns to Perch as Dow Top-Performing Stock

2018-08-18 247wallst
For the first time since May of last year, Apple Inc. (NASDAQ: AAPL) has returned to the top of the chart as the Dow Jones industrial average’s best-performing stock for the year to date. The stock traded about flat for the first two days of the week and bounced — along with the Dow itself — on Wednesday. Apple stock added 4.84% last week, and for the year to date has added 28.6%.
BRK.A V NKE MRK AAPL MSFT GM

90
7 Stocks Warren Buffett Can’t Stop Buying

2018-08-17 investorplace - 2
Sometimes identifying the best stocks to buy can be difficult, but you could do a lot worse than checking out the stocks selected by one of the world’s savviest hedge fund managers — Warren Buffett.
TEVA TEVVF GOOG USB BRK.A TEVJF BK GOOGL AAPL TSLA GM DAL LUV

15
Tesla stock sinks after Musk gives tearful NYT interview - Channel NewsAsia

2018-08-17 channelnewsasia - 1
Tesla Inc's shares slumped 8 percent on Friday after Chief Executive Elon Musk told the New York Times his tweet about taking the company private was not reviewed by anybody, and a brokerage raised doubts about the profitability of the electric carmaker's Model 3 sedan.
NYTAB GM 9696

Related Articles

REPH: Recro Pharma Analysis and Research Report

15h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

15h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

16h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...